These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29701140)

  • 1. Expression of Plasma hsa-miR122 in HBV-Related Hepatocellular Carcinoma (HCC) in Vietnamese Patients.
    Quoc NB; Phuong NDN; Ngan TK; Linh NTM; Cuong PH; Chau NNB
    Microrna; 2018; 7(2):92-99. PubMed ID: 29701140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
    Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
    PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
    Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
    Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma.
    Ramakrishnan K; Vishwakarma R; Dev RR; Raju R; Rehman N
    OMICS; 2024 Jun; 28(6):280-290. PubMed ID: 38818956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells.
    Li A; Wu J; Zhai A; Qian J; Wang X; Qaria MA; Zhang Q; Li Y; Fang Y; Kao W; Song W; Zhang Z; Zhang F
    Int J Oncol; 2019 Nov; 55(5):1137-1148. PubMed ID: 31485598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
    Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
    BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
    Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
    Li L; Guo Z; Wang J; Mao Y; Gao Q
    Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
    Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J
    Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
    PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma.
    She S; Xiang Y; Yang M; Ding X; Liu X; Ma L; Liu Q; Liu B; Lu Z; Li S; Liu Y; Ran X; Xu X; Hu H; Hu P; Zhang D; Ren H; Yang Y
    Int J Oncol; 2015 Aug; 47(2):543-54. PubMed ID: 26058824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.